AMS Congress 2018

AMS Congress 2018

“In 2018 our Congress will be in the warmth and sun of the Sunshine State and and the warm friendship of AMS colleagues.

Life is all about choices and so is the management of menopause.

National and international speakers will discuss midlife choices – hormonal v non-hormonal, weight loss choices, bone preservation choices, and risk reduction choices.

Discuss difficult cases, and learn all the latest from the literature and the clinical trials.

Meet with friends and colleagues and exchange ideas.

Expand your knowledge on

– primary vs secondary prevention of chronic disease
– choices for risk reduction surgery
– hormonal vs non-hormonal management of menopause
– diet vs pharmacotherapy vs surgery for weight management
– gender choices”
“In 2018 our Congress will be in the warmth and sun of the Sunshine State and and the warm friendship of AMS colleagues.

Life is all about choices and so is the management of menopause.

National and international speakers will discuss midlife choices – hormonal v non-hormonal, weight loss choices, bone preservation choices, and risk reduction choices.

Discuss difficult cases, and learn all the latest from the literature and the clinical trials.

Meet with friends and colleagues and exchange ideas.

Expand your knowledge on

– primary vs secondary prevention of chronic disease
– choices for risk reduction surgery
– hormonal vs non-hormonal management of menopause
– diet vs pharmacotherapy vs surgery for weight management
– gender choices”
“In 2018 our Congress will be in the warmth and sun of the Sunshine State and and the warm friendship of AMS colleagues.

Life is all about choices and so is the management of menopause.

National and international speakers will discuss midlife choices – hormonal v non-hormonal, weight loss choices, bone preservation choices, and risk reduction choices.

Discuss difficult cases, and learn all the latest from the literature and the clinical trials.

Meet with friends and colleagues and exchange ideas.

Expand your knowledge on

– primary vs secondary prevention of chronic disease
– choices for risk reduction surgery
– hormonal vs non-hormonal management of menopause
– diet vs pharmacotherapy vs surgery for weight management
– gender choices”

5-Continent-Congress

5-Continent-Congress

The 5CC has established itself as one of the top aesthetic meetings in the world, and has grown significantly in the past few years. We are pleased to announce that the 8th 5CC was an exceptional success, with close to 1,000 attendees from 71 countries and five continents, over 200 expert faculty speakers, a sold-out industry exhibition with over 75 highly-regarded companies in the aesthetic field and 250 of their best representatives.

With that said, we still intend to enhance the 5CC even further in 2018. Join us in Barcelona from August 30 – September 2, 2018 at the stunning Centre de Convencions Internacional de Barcelona (CCIB). This location is an integral part of Diagonal Mar, the newest section of Barcelona’s seafront, in the heart of the technology and business district known as Barcelona 22@. This ensures short paths to the beach, world-class hotels, all kind of attractions and entertainment and will offer you an incredible setting for our 9th 5CC.
The 5CC has established itself as one of the top aesthetic meetings in the world, and has grown significantly in the past few years. We are pleased to announce that the 8th 5CC was an exceptional success, with close to 1,000 attendees from 71 countries and five continents, over 200 expert faculty speakers, a sold-out industry exhibition with over 75 highly-regarded companies in the aesthetic field and 250 of their best representatives.

With that said, we still intend to enhance the 5CC even further in 2018. Join us in Barcelona from August 30 – September 2, 2018 at the stunning Centre de Convencions Internacional de Barcelona (CCIB). This location is an integral part of Diagonal Mar, the newest section of Barcelona’s seafront, in the heart of the technology and business district known as Barcelona 22@. This ensures short paths to the beach, world-class hotels, all kind of attractions and entertainment and will offer you an incredible setting for our 9th 5CC.The 5CC has established itself as one of the top aesthetic meetings in the world, and has grown significantly in the past few years. We are pleased to announce that the 8th 5CC was an exceptional success, with close to 1,000 attendees from 71 countries and five continents, over 200 expert faculty speakers, a sold-out industry exhibition with over 75 highly-regarded companies in the aesthetic field and 250 of their best representatives.

With that said, we still intend to enhance the 5CC even further in 2018. Join us in Barcelona from August 30 – September 2, 2018 at the stunning Centre de Convencions Internacional de Barcelona (CCIB). This location is an integral part of Diagonal Mar, the newest section of Barcelona’s seafront, in the heart of the technology and business district known as Barcelona 22@. This ensures short paths to the beach, world-class hotels, all kind of attractions and entertainment and will offer you an incredible setting for our 9th 5CC.

9th International Conference and Exhibition on Pharmaceutical Biotechnology & Biomedical Engineering

9th International Conference and Exhibition on Pharmaceutical Biotechnology & Biomedical Engineering

“World Congress on Pharmaceutical Biotechnology and Bioengineering Conference is scheduled to be held during March 25-26, at Orlando, USA. This Pharma Biotech & Biomed includes a wide range of Keynote presentations, plenary talks, Symposia, Workshops, Exhibitions, Poster presentations and Career development programs with an audience from various areas of Pharma Biotech and Biomedical assembling experts from Academy and Research-Professors, Assistant Professors, PhD Scholars, Pharmaceutical Associations and Societies, Pharmaceutical Business Entrepreneurs, Pharmaceutical Manufacturing Companies, Medical Devices Manufacturing Companies, Directors, CEO’s of Organizations, CROs and Clinical Data Management Companies.

This meeting focuses on the trends which the biotechnology and Biomedical market is heading on since its launch till the present date and moving on to the projections in future. It takes into its fold the critical developmental procedures, analyses, regulatory factors including post marketing surveillance and clinical studies. Innovation and compliance to regulatory guidelines are the most critical aspects.””World Congress on Pharmaceutical Biotechnology and Bioengineering Conference is scheduled to be held during March 25-26, at Orlando, USA. This Pharma Biotech & Biomed includes a wide range of Keynote presentations, plenary talks, Symposia, Workshops, Exhibitions, Poster presentations and Career development programs with an audience from various areas of Pharma Biotech and Biomedical assembling experts from Academy and Research-Professors, Assistant Professors, PhD Scholars, Pharmaceutical Associations and Societies, Pharmaceutical Business Entrepreneurs, Pharmaceutical Manufacturing Companies, Medical Devices Manufacturing Companies, Directors, CEO’s of Organizations, CROs and Clinical Data Management Companies.

This meeting focuses on the trends which the biotechnology and Biomedical market is heading on since its launch till the present date and moving on to the projections in future. It takes into its fold the critical developmental procedures, analyses, regulatory factors including post marketing surveillance and clinical studies. Innovation and compliance to regulatory guidelines are the most critical aspects.”

Flux Congress

Flux Congress

The Flux Congress aims is to advance the understanding of human brain development by serving as a forum for professional and student scientists, physicians, and educators to exchange information and educate the next generation of developmental cognitive neuroscience researchers, encourage translational research to clinical populations, promote public information by discussing implications on the fields of education, and encourage further progress in the field of developmental cognitive neuroscience.
The Flux Congress aims is to advance the understanding of human brain development by serving as a forum for professional and student scientists, physicians, and educators to exchange information and educate the next generation of developmental cognitive neuroscience researchers, encourage translational research to clinical populations, promote public information by discussing implications on the fields of education, and encourage further progress in the field of developmental cognitive neuroscience.The Flux Congress aims is to advance the understanding of human brain development by serving as a forum for professional and student scientists, physicians, and educators to exchange information and educate the next generation of developmental cognitive neuroscience researchers, encourage translational research to clinical populations, promote public information by discussing implications on the fields of education, and encourage further progress in the field of developmental cognitive neuroscience.The Flux Congress aims is to advance the understanding of human brain development by serving as a forum for professional and student scientists, physicians, and educators to exchange information and educate the next generation of developmental cognitive neuroscience researchers, encourage translational research to clinical populations, promote public information by discussing implications on the fields of education, and encourage further progress in the field of developmental cognitive neuroscience.The Flux Congress aims is to advance the understanding of human brain development by serving as a forum for professional and student scientists, physicians, and educators to exchange information and educate the next generation of developmental cognitive neuroscience researchers, encourage translational research to clinical populations, promote public information by discussing implications on the fields of education, and encourage further progress in the field of developmental cognitive neuroscience.

47th World Congress on Nursing & Health Care

47th World Congress on Nursing & Health Care

ConferenceSeries llc Ltd merrily welcomes you to attend 47th World Congress on Nursing and Healthcare, during August 22-23, 2018, Singapore, with a theme, “Nursing: Education, Healthcare and research in practice”.

ConferenceSeries llc Ltd Organizes 1000+ conferences every year across the USA, Europe and Asia with support from 1000 and more scientific societies and publishes 700+ open access journals with over 100,000 eminent personalities, reputed scientists as editorial board members.

This year World Nursing Congress 2018 meeting makes a stage for specialist’s cooperation at the same time it is a global platform to discuss and learn about exchange research evidence, innovative ideas and models of best practice.

World Nursing Congress 2018 covers a wide range of nursing topics such as Nursing Education, Nursing Practice, Healthcare Management, Nursing Types, Pediatric Nursing, Midwifery and maternal aid, Community Nursing, Emergency Nursing, Clinical Nursing, Mental Health Nursing, Critical care Nursing.

The World Nursing Congress 2018 organizing committee is confident that participants will benefit from the high value scientific program. We welcome all the researchers/practitioners to join us at Singapore for two days of stimulating discussions, knowledge sharing, and networking events.

ConferenceSeries llc Ltd Organizes 1000+ conferences every year across the USA, Europe and Asia with support from 1000 and more scientific societies and publishes 700+ open access journals with over 100,000 eminent personalities, reputed scientists as editorial board members.

This year World Nursing Congress 2018 meeting makes a stage for specialist’s cooperation at the same time it is a global platform to discuss and learn about exchange research evidence, innovative ideas and models of best practice.

World Nursing Congress 2018 covers a wide range of nursing topics such as Nursing Education, Nursing Practice, Healthcare Management, Nursing Types, Pediatric Nursing, Midwifery and maternal aid, Community Nursing, Emergency Nursing, Clinical Nursing, Mental Health Nursing, Critical care Nursing.

The World Nursing Congress 2018 organizing committee is confident that participants will benefit from the high value scientific program. We welcome all the researchers/practitioners to join us at Singapore for two days of stimulating discussions, knowledge sharing, and networking events.

7th Annual Pharma Anti-Counterfeiting & Serialisation 2018

7th Annual Pharma Anti-Counterfeiting & Serialisation 2018

7th Annual Pharma Anti-Counterfeiting & Serialisation 2018
“Competences to Combat Counterfeits”
12th & 13th September 2018, Sheraton Skyline Hotel, London Heathrow, UK
7th Annual Pharma Anti-Counterfeiting & Serialisation 2018 overviews and integrates the business and technical problems that pharmaceutical companies should be aware of in order to fight the major global problem of counterfeit medicines. The Delegated Act includes several unexpected rules that add complexity to FMD planning and preparation. Many supply chain companies have raised questions related to the impending Delegated Act requirements and we could find answers for all of them at our conference. In addition to discussion of the problems, this conference addresses serialisation, track and trace analytical techniques scientists use to detect counterfeits and identifying solutions to the threat of counterfeit medical products.
SPONSORS:
• Principal Sponsor: FarmaTrust
• Silver Sponsor: Ant Tail
KEY SPEAKERS:
• DARIUS-JEAN NAMDJOU, Associate Director Global Regulatory Affairs, Grunenthal
• ANNA LUCZAK, Scientist – Global Analytical Technology Group, Bristol-Myers Squibb (USA)
• GEOFFROY BESSAUD, Associate Vice-President, Corporate Anti-Counterfeiting Coordination, Sanofi
• JOHN SIMMONS, Serialization and Coding Quality Lead, GSK
• CINZIA MARCON, Supply Chain and Quality Operations (SCMQO) Manager, Pfizer
• GIANPIERO LORUSSO, Director, Supply Operations, Merck
• DAVIDE SMALDONE, Corporate Demand Manager, Menarini
• MAARTEN VAN BAELEN, Market Access Director, Medicines for Europe
• MIKE ISLES, Executive Director, European Alliance for Access to Safe Medicines
• BAWAN AHMED, Specialist Pharmaceutical Assessor, Kurdistan Regional Government
• GLEN HODGSON, Head of Healthcare, GS1
• SULTAN DAJANI, Community Pharmacist, Royal Pharmaceutical Society
• SANDY EISEN, CMO, Frontline Pharma
• EVELINE VAN KEYMEULEN, Counsel Advocaat, Member of the New York Bar, Allen & Overy

7th Annual Pharma Anti-Counterfeiting & Serialisation 2018
“Competences to Combat Counterfeits”
12th & 13th September 2018, Sheraton Skyline Hotel, London Heathrow, UK
7th Annual Pharma Anti-Counterfeiting & Serialisation 2018 overviews and integrates the business and technical problems that pharmaceutical companies should be aware of in order to fight the major global problem of counterfeit medicines. The Delegated Act includes several unexpected rules that add complexity to FMD planning and preparation. Many supply chain companies have raised questions related to the impending Delegated Act requirements and we could find answers for all of them at our conference. In addition to discussion of the problems, this conference addresses serialisation, track and trace analytical techniques scientists use to detect counterfeits and identifying solutions to the threat of counterfeit medical products.

GUT HEALTH CONGRESS ASIA

GUT HEALTH CONGRESS ASIA

This event will highlight cutting-edge research and business collaboration strategies through expert presentations and case studies. Panel discussions will explore in detail some of the key issues in this subject area. An exhibition filled with solution providers showcasing their products and technology, as well as networking breaks will help promote interaction and business reach with your peers.
If you are looking to either learn more from the top scientists in the gastrointestinal, microbiome or probiotics space, showcase exciting developments in your research or seek partnerships within the industry; this is a congress not be missed – GUT HEALTH CONGRESS ASIA 2018
This event will highlight cutting-edge research and business collaboration strategies through expert presentations and case studies. Panel discussions will explore in detail some of the key issues in this subject area. An exhibition filled with solution providers showcasing their products and technology, as well as networking breaks will help promote interaction and business reach with your peers.
If you are looking to either learn more from the top scientists in the gastrointestinal, microbiome or probiotics space, showcase exciting developments in your research or seek partnerships within the industry; this is a congress not be missed – GUT HEALTH CONGRESS ASIA 2018
This event will highlight cutting-edge research and business collaboration strategies through expert presentations and case studies. Panel discussions will explore in detail some of the key issues in this subject area. An exhibition filled with solution providers showcasing their products and technology, as well as networking breaks will help promote interaction and business reach with your peers.
If you are looking to either learn more from the top scientists in the gastrointestinal, microbiome or probiotics space, showcase exciting developments in your research or seek partnerships within the industry; this is a congress not be missed – GUT HEALTH CONGRESS ASIA 2018

International Conference on Alzheimers, Dementia and Related Neurodegenerative Diseases

International Conference on Alzheimers, Dementia and Related Neurodegenerative Diseases

Madrid is all set for an amazing event as PULSUS proudly presents the “International Conference on Alzheimers, Dementia and Related Neurodegenerative Diseases” slated on December 03-04, 2018 in Madrid, Spain. The theme of the conference is “Leading Advancements and Remedies in the Neurodegenerative Disorders”.
Madrid is all set for an amazing event as PULSUS proudly presents the “International Conference on Alzheimers, Dementia and Related Neurodegenerative Diseases” slated on December 03-04, 2018 in Madrid, Spain. The theme of the conference is “Leading Advancements and Remedies in the Neurodegenerative Disorders”.
Madrid is all set for an amazing event as PULSUS proudly presents the “International Conference on Alzheimers, Dementia and Related Neurodegenerative Diseases” slated on December 03-04, 2018 in Madrid, Spain. The theme of the conference is “Leading Advancements and Remedies in the Neurodegenerative Disorders”.
Madrid is all set for an amazing event as PULSUS proudly presents the “International Conference on Alzheimers, Dementia and Related Neurodegenerative Diseases” slated on December 03-04, 2018 in Madrid, Spain. The theme of the conference is “Leading Advancements and Remedies in the Neurodegenerative Disorders”.

Madrid is all set for an amazing event as PULSUS proudly presents the “International Conference on Alzheimers, Dementia and Related Neurodegenerative Diseases” slated on December 03-04, 2018 in Madrid, Spain. The theme of the conference is “Leading Advancements and Remedies in the Neurodegenerative Disorders”.
Madrid is all set for an amazing event as PULSUS proudly presents the “International Conference on Alzheimers, Dementia and Related Neurodegenerative Diseases” slated on December 03-04, 2018 in Madrid, Spain. The theme of the conference is “Leading Advancements and Remedies in the Neurodegenerative Disorders”.

Madrid is all set for an amazing event as PULSUS proudly presents the “International Conference on Alzheimers, Dementia and Related Neurodegenerative Diseases” slated on December 03-04, 2018 in Madrid, Spain. The theme of the conference is “Leading Advancements and Remedies in the Neurodegenerative Disorders”.
Madrid is all set for an amazing event as PULSUS proudly presents the “International Conference on Alzheimers, Dementia and Related Neurodegenerative Diseases” slated on December 03-04, 2018 in Madrid, Spain. The theme of the conference is “Leading Advancements and Remedies in the Neurodegenerative Disorders”.

Clinical Evaluation Report for Europe and MEDDEV Expectations: Impact with New Medical Device Regulations (MDR)

Clinical Evaluation Report for Europe and MEDDEV Expectations: Impact with New Medical Device Regulations (MDR)

“Course “”Clinical Evaluation Report for Europe and MEDDEV Expectations: Impact with New Medical Device Regulations (MDR)”” has been pre-approved by RAPS as eligible for up to 12 credits towards a participant’s RAC recertification upon full completion.
Overview:
Why you should attend
• Introduction to MEDDEV 2.7.1, Revision 4 (2016)
• This revised MEDDEV is generated within a context of increased scrutiny on the Notified Bodies (NB) by the Joint Assessments from the Competent Authorities, which has led to an increase in the level of review the NB exercise over clinical evaluations
• Frequency for updating the CER is also much more prescriptive now and you must define and justify the frequency, based on “”significant risk”” of the device, as well as how “”well-established””
• One of the largest changes in this revision, the demonstration of “”equivalence”” is much harder now
• Revision will lead to more clinical investigations, probably of larger size and notified bodies will be looking more closely at how all the essential requirements are met, including those regarding usability
• Manufacturers should start discussing with their notified bodies how they will start implementing these new requirements and to start performing their gap assessments and resource needs-assessments now
• General considerations on updating the clinical evaluation
• How is a clinical evaluation performed?
• Appraisal of pertinent data
• The role of the notified body in the assessment of clinical evaluation reports and key changes in 2016
• Implement risk evaluation pre/post review
• Establish design and intended use equivalence with competitor and preexisting designs
• Identify data available from the clinical literature
• Supply and prepare documentation relating to clinical investigations that meets Notified Body requirements (if clinical investigation was deemed necessary and completed)
• Demonstrate that there is sufficient clinical data to meet the safety and performance requirements of the device
• Identify residual clinical risks and determine whether post-market clinical follow-up is required
• Maintain and update clinical evaluation documentation throughout post-market product lifecycle
• The initial creation of a CER can be a painstakingly long process, and for smaller manufacturers, can prove quite burdensome – learn how to complete a literature review report which is a comprehensive analysis of available pre- and post-market clinical data relevant to the intended use of the device and includes clinical performance and safety data
• Learn how the new MDR for Europe has a direct impact on the CER going forward
• Why CERs need to be reassessed under the new MDR
• Learn how to plan for a gap assessment to transition an organization to compliance for your CER under Europe’s Medical Device Regulation 2017/745″